18 juni, 2025 Regulatoriskt LSIF invests SEK 1 million in AcuCort through exercise of warrants – strong support ahead of final day for exercising TO 2
17 juni, 2025 Regulatoriskt AcuCort signs Letter of Intent (LOI) with Glenmark Pharmaceuticals for Germany and five additional European countries
10 juni, 2025 Regulatoriskt AcuCort signs Letter of Intent (LOI) with Lunatus for the Middle East and Gulf States
12 maj, 2025 Regulatoriskt AcuCort receives new order for Zeqmelit® – strong development in the Nordic market
19 mars, 2025 Icke-regulatoriskt AcuCort receives renewed marketing authorisation for Zeqmelit® in Norway
17 mars, 2025 Icke-regulatoriskt AcuCort receives renewed marketing authorisation for Zeqmelit® in Denmark
4 mars, 2025 Icke-regulatoriskt AcuCort’s medicinal product receives renewed marketing authorisation from the Swedish Medical Products Agency
27 januari, 2025 Icke-regulatoriskt Promising results from AcuCort’s Phase IV study – scientific articles under preparation for international publication
17 januari, 2025 Regulatoriskt AcuCort's Chairman subscribes for an additional approximately SEK 200,000 in the ongoing rights issue
14 januari, 2025 Regulatoriskt AcuCort’s CEO subscribes for an additional SEK 1 million in the ongoing rights issue, bringing total commitment to approximately SEK 2 million